TGFB1 and neoplasm: Tregs promote tumor growth by inhibiting the antitumor immune functions of effector T cells, NK cells, and DCs through various pathways: (1) Secreting IL-10, TGF-β, and IL-35, which suppress immune functions via IL-10-dependent pathways.